1. Home
  2. WOLF vs AVXL Comparison

WOLF vs AVXL Comparison

Compare WOLF & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOLF
  • AVXL
  • Stock Information
  • Founded
  • WOLF 1987
  • AVXL 2001
  • Country
  • WOLF United States
  • AVXL United States
  • Employees
  • WOLF N/A
  • AVXL N/A
  • Industry
  • WOLF Semiconductors
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WOLF Technology
  • AVXL Health Care
  • Exchange
  • WOLF Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • WOLF 843.2M
  • AVXL 779.5M
  • IPO Year
  • WOLF 1993
  • AVXL N/A
  • Fundamental
  • Price
  • WOLF $6.84
  • AVXL $8.35
  • Analyst Decision
  • WOLF Hold
  • AVXL Strong Buy
  • Analyst Count
  • WOLF 16
  • AVXL 2
  • Target Price
  • WOLF $14.86
  • AVXL $44.00
  • AVG Volume (30 Days)
  • WOLF 18.8M
  • AVXL 1.0M
  • Earning Date
  • WOLF 01-29-2025
  • AVXL 02-12-2025
  • Dividend Yield
  • WOLF N/A
  • AVXL N/A
  • EPS Growth
  • WOLF N/A
  • AVXL N/A
  • EPS
  • WOLF N/A
  • AVXL N/A
  • Revenue
  • WOLF $776,600,000.00
  • AVXL N/A
  • Revenue This Year
  • WOLF N/A
  • AVXL N/A
  • Revenue Next Year
  • WOLF $28.15
  • AVXL N/A
  • P/E Ratio
  • WOLF N/A
  • AVXL N/A
  • Revenue Growth
  • WOLF N/A
  • AVXL N/A
  • 52 Week Low
  • WOLF $4.66
  • AVXL $3.25
  • 52 Week High
  • WOLF $30.86
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • WOLF 55.11
  • AVXL 40.39
  • Support Level
  • WOLF $4.92
  • AVXL $8.50
  • Resistance Level
  • WOLF $7.67
  • AVXL $9.20
  • Average True Range (ATR)
  • WOLF 0.55
  • AVXL 0.49
  • MACD
  • WOLF 0.24
  • AVXL -0.01
  • Stochastic Oscillator
  • WOLF 69.64
  • AVXL 32.23

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its necessary compound ANAVEX 2-73 is being developed to treat Alzheimer's disease, Parkinson's disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder. The company's operating segment is into developing novel therapies for the management of CNS diseases.

Share on Social Networks: